The Supreme Court’s Mifepristone Ruling & It’s Implications for Self-Funded Health Plans

Attorney Kendall Jackson reports how the June 2024 Supreme Court case of FDA v. Alliance for Hippocratic Medicine attracted a lot of national attention not only because of its implications for reproductive rights, but also because of the question related to the FDA’s regulatory power. The Supreme Court’s decision resulted in access to Mifepristone, an abortion medication, remaining unchanged, but the decision was based on a procedural issue rather than an effort to protect reproductive rights.